Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products

被引:443
作者
Dumitriu, IE
Baruah, P
Valentinis, B
Voll, RE
Herrmann, M
Nawroth, PP
Arnold, B
Bianchi, ME
Manfredi, AA
Rovere-Querini, P
机构
[1] H San Raffaele Sci Inst, Clin Immunol Unit, Canc Immunotherapy & Gene Therapy Program, Milan, Italy
[2] Molmed SPA, Milan, Italy
[3] Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol & Rheumatol, Erlangen, Germany
[4] Heidelberg Univ, Dept Med 1, Heidelberg, Germany
[5] Heidelberg Univ, Dept Neurol, Heidelberg, Germany
[6] German Canc Res Ctr, D-6900 Heidelberg, Germany
[7] Vita Slute San Raffaele Univ, Chromatin Dynam Unit, Milan, Italy
关键词
D O I
10.4049/jimmunol.174.12.7506
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
High mobility group box 1 (HMGB1) is an abundant and conserved nuclear protein that is released by necrotic cells and acts in the extracellular environment as a primary proinflammatory signal. In this study we show that human dendritic cells, which are specialized in Ag presentation to T cells, actively release their own HMGB1 into the extracellular milieu upon activation. This secreted HMGB1 is necessary for the up-regulation of CD80, CD83, and CD86 surface markers of human dendritic cells and for IL-12 production. The HMGB1 secreted by dendritic cells is also required for the clonal expansion, survival, and functional polarization of naive T cells. Using neutralizing Abs and receptor for advanced glycation end product-deficient (RAGE(-/-)) cells, we demonstrate that RAGE is required for the effect of HMGB1 on dendritic cells. HMGB1/RAGE interaction results in downstream activation of MAPKs and NF-kappa B. The use of an ancient signal of necrosis, HMGB1, by dendritic cells to sustain their own maturation and for activation of T lymphocytes represents a profitable evolutionary mechanism.
引用
收藏
页码:7506 / 7515
页数:10
相关论文
共 46 条
[1]
Opinion - Death-defying immunity: do apoptotic cells influence antigen processing and presentation? [J].
Albert, ML .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (03) :223-231
[2]
HMGB1 is a potent trigger of arthritis [J].
Andersson, U ;
Erlandsson-Harris, H .
JOURNAL OF INTERNAL MEDICINE, 2004, 255 (03) :344-350
[3]
High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes [J].
Andersson, U ;
Wang, HC ;
Palmblad, K ;
Aveberger, AC ;
Bloom, O ;
Erlandsson-Harris, H ;
Janson, A ;
Kokkola, R ;
Zhang, MH ;
Yang, H ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :565-570
[4]
The PI3 kinase, p38 SAP kinase, and NF-κB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells [J].
Ardeshna, KM ;
Pizzey, AR ;
Devereaux, S ;
Khwaja, A .
BLOOD, 2000, 96 (03) :1039-1046
[5]
Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]
Bellone M, 1997, J IMMUNOL, V159, P5391
[7]
Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death [J].
Bianchi, ME .
TRENDS IN CELL BIOLOGY, 2004, 14 (06) :287-293
[8]
Chromatin and cell death [J].
Bianchi, ME ;
Manfredi, A .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2004, 1677 (1-3) :181-186
[9]
Diabetes-associated sustained activation of the transcription factor nuclear factor-κB [J].
Bierhaus, A ;
Schiekofer, S ;
Schwaninger, M ;
Andrassy, M ;
Humpert, PM ;
Chen, J ;
Hong, M ;
Luther, T ;
Henle, T ;
Klöting, I ;
Morcos, M ;
Hofmann, M ;
Tritschler, H ;
Weigle, B ;
Kasper, M ;
Smith, M ;
Perry, G ;
Schmidt, AM ;
Stern, DM ;
Häring, HU ;
Schleicher, E ;
Nawroth, PP .
DIABETES, 2001, 50 (12) :2792-2808
[10]
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion [J].
Bonaldi, T ;
Talamo, F ;
Scaffidi, P ;
Ferrera, D ;
Porto, A ;
Bachi, A ;
Rubartelli, A ;
Agresti, A ;
Bianchi, ME .
EMBO JOURNAL, 2003, 22 (20) :5551-5560